Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rothman

Showing results (271-280 of 532) with videos related to

Pageof 54
Sort By:
Bioorganic & Medicinal Chemistry|November 14, 1997
Libraries of opiate and anti-opiate peptidomimetics containing 2,3-methanoleucineK Burgess, W Li, D S Linthicum, et al.
Journal of Hepatology|May 1, 1992
Central mu-opioid receptors are down-regulated in a rat model of cholestasisN V Bergasa, R B Rothman, J Vergalla, et al.
Neurochemical Research|March 1, 1992
MPTP lesions of the nigrostriatal dopaminergic projection decrease [3H]1-[1-(2-thienyl)cyclohexyl]piperidine binding to PCP site 2: further evidence that PCP site 2 is associated with the biogenic amine reuptake complexH C Akunne, J N Johannessen, B R de Costa, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivoE J Bilsky, R N Bernstein, V J Hruby, et al.
Methods in Enzymology|November 2, 2010
In vitro and in vivo assessment of mu opioid receptor constitutive activityEdward J Bilsky, Denise Giuvelis, Melissa D Osborn, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 15, 2009
Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the ratMichael H Baumann, Dorota Zolkowska, Insook Kim, et al.
Neuroreport|October 27, 1994
Pharmacological characterization of the cloned kappa opioid receptor as a kappa 1b subtypeJ Lai, S W Ma, R H Zhu, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 29, 2005
Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogsS Wee, K G Anderson, M H Baumann, et al.
Diabetes|December 16, 2000
Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD miceD V Serreze, C M Post, H D Chapman, et al.
Peptides|January 1, 1995
Opioid peptide receptor studies. 1. Identification of a novel delta-opioid receptor binding site in rat brain membranesX Y Cha, H Xu, K C Rice, et al.
Pageof 54

Showing results (271-280 of 532) with videos related to

Sort By:
Pageof 54
Bioorganic & Medicinal Chemistry|November 14, 1997
Libraries of opiate and anti-opiate peptidomimetics containing 2,3-methanoleucineK Burgess, W Li, D S Linthicum, et al.
Journal of Hepatology|May 1, 1992
Central mu-opioid receptors are down-regulated in a rat model of cholestasisN V Bergasa, R B Rothman, J Vergalla, et al.
Neurochemical Research|March 1, 1992
MPTP lesions of the nigrostriatal dopaminergic projection decrease [3H]1-[1-(2-thienyl)cyclohexyl]piperidine binding to PCP site 2: further evidence that PCP site 2 is associated with the biogenic amine reuptake complexH C Akunne, J N Johannessen, B R de Costa, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivoE J Bilsky, R N Bernstein, V J Hruby, et al.
Methods in Enzymology|November 2, 2010
In vitro and in vivo assessment of mu opioid receptor constitutive activityEdward J Bilsky, Denise Giuvelis, Melissa D Osborn, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 15, 2009
Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the ratMichael H Baumann, Dorota Zolkowska, Insook Kim, et al.
Neuroreport|October 27, 1994
Pharmacological characterization of the cloned kappa opioid receptor as a kappa 1b subtypeJ Lai, S W Ma, R H Zhu, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 29, 2005
Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogsS Wee, K G Anderson, M H Baumann, et al.
Diabetes|December 16, 2000
Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD miceD V Serreze, C M Post, H D Chapman, et al.
Peptides|January 1, 1995
Opioid peptide receptor studies. 1. Identification of a novel delta-opioid receptor binding site in rat brain membranesX Y Cha, H Xu, K C Rice, et al.
Pageof 54